The research team built an AI-powered drug discovery platform that rapidly and cost-effectively generates novel drug candidates. By integrating AI, computational chemistry, and bioinformatics, the team's technology addresses the inefficiencies of traditional pharmaceutical R&D, reducing toxicity risks and improving success rates. Leading global pharma companies have shown strong interest in this approach, and the team is actively pursuing commercialisation through strategic partnerships, licensing, and pipeline sales to bring innovative therapies to market.

Team of Department of Chemistry, Faculty of Science:

Prof. Chi-Ming CHE

Professor, Chair of Chemistry

Dr. Serena YANG

CEO of AILSI (AI and Life Sciences Institute (HK)

Research Assistant Professor

Email: cmche@hku.hk; guanya@connect.hku.hk